Parabilis Medicines Director Buys $474,000 in Shares Following IPO
Director Alan Sebulsky acquired 17,500 shares of Parabilis Medicines for $474,000 at a weighted average price of $27.06 per share shortly after the company's IPO, increasing his stake to 30,000 shares held through a controlled entity.
Director Alan Sebulsky acquired 17,500 shares of Parabilis Medicines (PBLS) for $474,000, based on a weighted average purchase price of $27.06 per share. The transaction increased his ownership to 30,000 shares, held through an entity he controls.
The purchase occurred shortly after Parabilis Medicines completed its initial public offering, making Sebulsky's transaction one of the first insider purchases in the company's history as a public entity. The pharmaceutical company had recently begun trading on public markets.
Continue reading
3 more paragraphs for subscribers.
Free readers get a daily preview and the weekly long-form. Premium unlocks every brief in full, AM & PM editions, alerts, and the archive.